Anivance AI is a biotech startup that provides AI with organ-on-a-chip technology to transform drug discovery and preclinical research.
Anivance AI Corporation has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Anivance AI Corporation's investors include DERYUN.
Anivance AI Corporation is headquartered in Hsinchu, Taiwan.
Anivance AI is a biotech startup that provides AI with organ-on-a-chip technology to transform drug discovery and preclinical research.
Anivance AI Corporation is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anivance AI Corporation — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/anivance-ai-corporation. Accessed July 26, 2026.
VCBacked. (2025). Anivance AI Corporation — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/anivance-ai-corporation
{{cite web |title=Anivance AI Corporation — Funding & Investors |url=https://www.vcbacked.co/company/anivance-ai-corporation |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated